John Y. Caloz
2021
In 2021, John Y. Caloz earned a total compensation of $500K as Chief Financial Officer, Treasurer and Senior Vice President at CytRx, which was the same as previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $400,000 |
| Total | $500,000 |
Caloz received $400K in salary, accounting for 80% of the total pay in 2021.
Caloz also received $100K in bonus.
Rankings
In 2021, John Y. Caloz's compensation ranked 10,724th out of 12,415 executives tracked by ExecPay. In other words, Caloz earned more than 13.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,724 out of 12,415 | 14th |
Division Manufacturing | 4,730 out of 5,508 | 14th |
Major group Chemicals And Allied Products | 2,125 out of 2,378 | 11th |
Industry group Drugs | 1,888 out of 2,099 | 10th |
Industry Biological Products, Except Diagnostic Substances | 416 out of 449 | 7th |
Source: SEC filing on June 16, 2022.
Caloz's colleagues
We found one more compensation record of an executive who worked with John Y. Caloz at CytRx in 2021.
2021
Steven Kriegsman
CytRx
Chief Executive Officer
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019